Royal Bank of Canada’s AbbVie ABBV Stock Holding History

Royal Bank of Canada’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$92.4M	Buy	425,000 +123,700	+41%	+$27.4M	0.02%	661
2025 Q4	$68.8M	Sell	301,300 -372,800	-55%	-$84.9M	0.01%	803
2025 Q3	$156M	Buy	674,100 +274,100	+69%	+$55.8M	0.03%	511
2025 Q2	$74.2M	Sell	400,000 -576,000	-59%	-$107M	0.01%	752
2025 Q1	$204M	Buy	976,000 +876,000	+876%	+$170M	0.04%	346
2024 Q4	$17.8M	Buy	+100,000	New	+$18.4M	﹤0.01%	1428
2024 Q1	–	Sell	-45,400	Closed	-$7.04M	–	6939
2023 Q4	$7.04M	Buy	+45,400	New	+$6.62M	﹤0.01%	1992
2022 Q4	–	Sell	-454,000	Closed	-$60.9M	–	7160
2022 Q3	$60.9M	Buy	+454,000	New	+$65.1M	0.02%	582
2021 Q4	–	Sell	-12,000	Closed	-$1.29M	–	7609
2021 Q3	$1.29M	Sell	12,000 -38,000	-76%	-$4.34M	﹤0.01%	3466
2021 Q2	$5.63M	Hold	50,000	–	–	﹤0.01%	2234
2021 Q1	$5.41M	Sell	50,000 -110,900	-69%	-$11.9M	﹤0.01%	2188
2020 Q4	$17.2M	Hold	160,900	–	–	0.01%	1347
2020 Q3	$14.1M	Sell	160,900 -43,300	-21%	-$4.08M	0.01%	1313
2020 Q2	$20M	Buy	204,200 +11,100	+6%	+$977K	0.01%	1038
2020 Q1	$14.7M	Buy	193,100 +1,900	+1%	+$162K	0.01%	1083
2019 Q4	$16.9M	Sell	191,200 -7,700	-4%	-$639K	0.01%	1264
2019 Q3	$15.1M	Buy	198,900 +167,400	+531%	+$11.5M	0.01%	1259
2019 Q2	$2.29M	Sell	31,500 -1,900	-6%	-$149K	﹤0.01%	2642
2019 Q1	$2.69M	Sell	33,400 -21,900	-40%	-$1.79M	﹤0.01%	2472
2018 Q4	$5.1M	Buy	55,300 +25,300	+84%	+$2.22M	﹤0.01%	1968
2018 Q3	$2.84M	Hold	30,000	–	–	﹤0.01%	2574
2018 Q2	$2.78M	Sell	30,000 -17,400	-37%	-$1.7M	﹤0.01%	2473
2018 Q1	$4.49M	Buy	47,400 +24,800	+110%	+$2.72M	﹤0.01%	2064
2017 Q4	$2.19M	Sell	22,600 -77,700	-77%	-$7.32M	﹤0.01%	2655
2017 Q3	$8.91M	Sell	100,300 -1,075,700	-91%	-$81.9M	﹤0.01%	1615
2017 Q2	$85.3M	Buy	1,176,000 +1,023,400	+671%	+$68.8M	0.04%	333
2017 Q1	$9.94M	Buy	152,600 +400	+0.3%	+$25.1K	0.01%	1494
2016 Q4	$9.53M	Sell	152,200 -62,100	-29%	-$3.79M	0.01%	1540
2016 Q3	$13.5M	Buy	214,300 +53,200	+33%	+$3.44M	0.01%	1263
2016 Q2	$9.97M	Buy	161,100 +56,500	+54%	+$3.44M	0.01%	1462
2016 Q1	$5.97M	Buy	104,600 +78,700	+304%	+$4.39M	﹤0.01%	1699
2015 Q4	$1.53M	Sell	25,900 -240,100	-90%	-$13.8M	﹤0.01%	2757
2015 Q3	$14.5M	Sell	266,000 -147,500	-36%	-$9.6M	0.01%	945
2015 Q2	$27.8M	Sell	413,500 -564,500	-58%	-$36.9M	0.02%	638
2015 Q1	$57.3M	Buy	978,000 +974,000	+24,350%	+$58.8M	0.04%	345
2014 Q4	$262K	Hold	4,000	–	–	﹤0.01%	4144
2014 Q3	$231K	Hold	4,000	–	–	﹤0.01%	4091
2014 Q2	$226K	Hold	4,000	–	–	﹤0.01%	4078
2014 Q1	$206K	Buy	+4,000	New	+$202K	﹤0.01%	4087

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada's ABBV Position: Q1 2026 in Review

Royal Bank of Canada reduced its AbbVie (ABBV) stake by 4.5% in Q1 2026, selling an estimated $78.9M and leaving 7,534,148 shares worth $1.64B. The position accounts for 0.29% of the portfolio, ranked #64.

Royal Bank of Canada first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.94B in Q3 2025. 4,090 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Royal Bank of Canada held 7,534,148 shares of AbbVie worth $1.64B as of Q1 2026.
Royal Bank of Canada sold 355,721 AbbVie shares in Q1 2026, an estimated $78.9M.
AbbVie made up 0.29% of Royal Bank of Canada's portfolio in Q1 2026, its #64 holding.
Royal Bank of Canada first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Royal Bank of Canada's AbbVie position peaked at $1.94B in Q3 2025.
4,090 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.